Eugene P. Kennedy serves as Executive at NEWLINK GENETICS CORP, where they oversee executive responsibilities. Since joining the company, Eugene P. Kennedy has executed 7 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on Feb 1, 2021 involved receiving (via award) 939 shares valued at $0.
Eugene P. Kennedy currently holds 11,423 shares of NEWLINK GENETICS CORP ((NLNK)), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Eugene P. Kennedy has been a net neutral trader of (NLNK) stock. They have purchased $0 and sold $0 worth of shares.
Eugene P. Kennedy's most recent insider trade was on Feb 1, 2021, when they sold 939 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |
| Jan 4, 2020 | (NLNK) | $831 | Payment | 376 | $2.21 | Discretionary |
| Jun 23, 2019 | (NLNK) | $564 | Payment | 359 | $1.57 | Discretionary |
| Jan 4, 2019 | (NLNK) | $583 | Payment | 376 | $1.55 | Discretionary |
| Jan 20, 2018 | (NLNK) | $733 | Payment | 85 | $8.62 | Discretionary |
| Jan 4, 2018 | (NLNK) | $4.1K | Payment | 409 | $10.06 | Discretionary |